Literature DB >> 12702033

Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population.

C L de Visser1, H J G Bilo, T F Thomsen, K H Groenier, B Meyboom-de Jong.   

Abstract

OBJECTIVES: To compare the estimation of coronary heart disease (CHD) risk by the Framingham risk score (FRS) and the Copenhagen risk score (CRS) using Dutch population data.
DESIGN: Comparison of CHD risk estimates from FRS and CRS. CHD risk-estimations for each separate risk factor.
SETTING: Urk, the Netherlands.
SUBJECTS: A total of 408 fishermen from Urk, aged 30-65 years, without pre-existing cardiovascular disease. MAIN OUTCOME MEASURES: Absolute CHD risk estimates.
RESULTS: The average 10-year risk for CHD was significantly different between the FRS (4.6%, SD 5.0) and the CRS (3.2%, SD 4.1). The correlation between the two estimates was 0.94 (P < 0.001). The Bland-Altman figure shows a large proportion of agreement, but with an increasing difference with increasing average risk. When examining the separate risk factors age, total cholesterol, HDL cholesterol and systolic blood pressure and smoking, there appear differences between the two risk functions.
CONCLUSION: Using Dutch population data, differences were found for the calculation of CHD risk with the FRS and the CRS. Further research must be carried out to examine the validity of these risk functions in the Dutch population.

Entities:  

Mesh:

Year:  2003        PMID: 12702033     DOI: 10.1046/j.1365-2796.2003.01137.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study.

Authors:  Justin M Bachmann; Benjamin L Willis; Colby R Ayers; Amit Khera; Jarett D Berry
Journal:  Circulation       Date:  2012-05-23       Impact factor: 29.690

2.  Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals.

Authors:  Anselm Mak; Jia Qing Lim; Yang Liu; Alicia Ai-cia Cheak; Roger Chun-man Ho
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

3.  Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).

Authors:  Ralph L Sacco; Minesh Khatri; Tatjana Rundek; Qiang Xu; Hannah Gardener; Bernadette Boden-Albala; Marco R Di Tullio; Shunichi Homma; Mitchell S V Elkind; Myunghee C Paik
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

4.  Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA).

Authors:  Billie Pettersson; Baishali Ambegaonkar; Vasilisa Sazonov; Mats Martinell; Jan Stålhammar; Per Wändell
Journal:  BMC Public Health       Date:  2010-11-29       Impact factor: 3.295

5.  Comparison of four cardiovascular risk prediction functions among Chinese patients with diabetes mellitus in the primary care setting.

Authors:  Fang Fang Jiao; Cindy Lo Kuen Lam; Colman Fung; Sarah Morag McGhee
Journal:  J Diabetes Investig       Date:  2014-02-11       Impact factor: 4.232

6.  Expanding the definition and classification of hypertension.

Authors:  Thomas D Giles; Bradford C Berk; Henry R Black; Jay N Cohn; John B Kostis; Joseph L Izzo; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-09       Impact factor: 3.738

7.  Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.

Authors:  P M Willemse; J Burggraaf; N A T Hamdy; N I Weijl; C Y Vossen; L van Wulften; A Q M J van Steijn-van Tol; F R Rosendaal; S Osanto
Journal:  Br J Cancer       Date:  2013-05-09       Impact factor: 7.640

8.  Re-calibration of coronary risk prediction: an example of the Seven Countries Study.

Authors:  Paolo Emilio Puddu; Paolo Piras; Daan Kromhout; Hanna Tolonen; Anthony Kafatos; Alessandro Menotti
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.